Article ; Online: Dual checkpoint T(h1)eamwork makes the anti-cancer dream work.
2024 Volume 57, Issue 3, Page(s) 406–408
Abstract: Combined anti-PD-L1+anti-CTLA-4 therapy has shown benefits over anti-PD-L1 monotherapy as a neoadjuvant treatment in head and neck cancer. In this issue of Immunity, Franken et al. report that ... ...
Abstract | Combined anti-PD-L1+anti-CTLA-4 therapy has shown benefits over anti-PD-L1 monotherapy as a neoadjuvant treatment in head and neck cancer. In this issue of Immunity, Franken et al. report that CD4 |
---|---|
MeSH term(s) | Humans ; CTLA-4 Antigen ; Head and Neck Neoplasms ; Combined Modality Therapy ; B7-H1 Antigen |
Chemical Substances | CTLA-4 Antigen ; B7-H1 Antigen |
Language | English |
Publishing date | 2024-03-13 |
Publishing country | United States |
Document type | Journal Article |
ZDB-ID | 1217235-2 |
ISSN | 1097-4180 ; 1074-7613 |
ISSN (online) | 1097-4180 |
ISSN | 1074-7613 |
DOI | 10.1016/j.immuni.2024.02.015 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 4227: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
|||
Zs.MG 69: Show issues |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.